D-day for women battling to get breast cancer drug Kadcyla

10 April 2017 - The drug Kadcyla is known to extend life by at least six months and in many case ...

Read more →

SMC - March 2017 decisions

13 March 2017 - The SMC has today published advice accepting a medicine used to treat follicular lymphoma for routine ...

Read more →

'Give us the chance to live': mum suffering from breast cancer begs for life-extending drug Kadcyla to be available on NHS

1 March 2017 - Lesley Stephen watched her friend Annie die of cancer after being refused the drug and decided to ...

Read more →

Botox to be prescribed on NHS in Scotland for migraine patients

13 February 2017 - Botox will be prescribed on the NHS in Scotland for the first time to treat patients ...

Read more →

SMC - February 2017 decisions

13 February 2017 - Treatments for cancer, cholesterol and chronic migraines among medicines accepted for routine use by NHS Scotland. ...

Read more →

SMC - January 2017 decisions

16 January 2017 - The Scottish Medicines Consortium has today published advice accepting four new medicines for routine use in ...

Read more →

Review of access to new medicines report

15 December 2016 - The Scottish Government has published Dr Brian Montgomery’s Review of Access to New Medicines, which assesses ...

Read more →

Scots miss out on breast cancer drug ‘withheld’ from NHS use

12 December 2016 - Scottish women will miss out on a drug that can shrink breast cancer tumours before surgery, ...

Read more →

SMC - December 2016 decisions

12 December 2016 - The Scottish Medicines Consortium has today published advice accepting a medicine used to treat advanced prostate ...

Read more →

Pancreatic cancer: new treatment could see advanced patients live twice as long

24 November 2016 - Advanced pancreatic cancer patients in Scotland may benefit from a new treatment which could allow them to ...

Read more →

SMC - November 2016 decisions

7 November 2016 - Five new medicines accepted for routine use in Scotland. ...

Read more →

People with an advanced form of thyroid cancer now able to benefit from Lenvima (lenvatinib mesylate) in Scotland

10 October 2016 - Patients in England denied access to lenvatinib mesylate due to administrative delays. ...

Read more →

Life-extending lung cancer drug approved for use in Scotland

10 October 2016 - Scotland has become the first part of the UK to approve a new life-extending treatment for ...

Read more →

SMC - October 2016 decisions

10 October 2016 - New treatments for thyroid cancer and lung cancer among five medicines accepted for routine use by ...

Read more →

Leading rheumatologist appointed new chair of SMC

7 October 2016 - One of Scotland’s leading rheumatologists has been appointed as the next chair of the SMC. ...

Read more →